Consistent with their function, it was found that the levels of KRAS-targeting miRNAs are decreased in CRC, highlighting miRNAs as potential diagnostic or prognostic biomarkers either as single factors or in panels of miRNAs. Here, KRAS is linked to colorectal carcinoma.